Grants for Small businesses - Federal

This funding opportunity supports large-scale clinical trials aimed at improving the diagnosis, treatment, and prevention of vision disorders, providing essential resources and services to a wide range of eligible organizations, including universities, nonprofits, and businesses.

This grant provides funding to community organizations, local and state governments, and tribal entities to implement strategies that reduce violence and enhance safety in high-risk neighborhoods across the United States.

This competition provides funding to U.S.-based businesses and teams to develop innovative solutions for efficiently recycling lithium-ion batteries, promoting sustainability and reducing reliance on foreign materials.

This funding opportunity supports the creation of essential research resources for biomedical studies related to infectious diseases, immune disorders, and vaccine development, aimed at a wide range of public and private organizations.

Notice of Funding Opportunity Summary NRCS is announcing the availability of Conservation Innovation Grants (CIG) State Program funding to stimulate the development and adoption of innovative conservation approaches and technologies. Applications are accepted from eligible entities (Section C) for projects carried out in the state of Texas. A total of up to $1,000,000 is available for the Texas CIG competition in FY 2024. All non-Foreign, non-federal entities (NFE) and individuals are invited to apply, with the sole exception of federal agencies. Projects may be between one and three years in duration. The maximum award amount for a single award in FY 2024 is $300,000. For new users of Grants.gov, see Section D. of the full Notice of Funding Opportunity for information about steps required before submitting an application via Grants.gov. Completing all steps required to start an application can take a significant amount of time, plan accordingly. Key Dates Applicants must submit their applications via Grants.gov by 11:59 pm Eastern Time on July 1, 2024. For technical issues with Grants.gov, contact Grants.gov Applicant Support at 1-800-518-4726 or [email protected]. Awarding agency staff cannot support applicants regarding Grants.gov accounts. For inquiries specific to the content of the NFO requirements, contact the federal awarding agency contact (section G of this NFO). Please limit questions to those regarding specific information contained in this NFO (such as dates, page numbers, clarification of discrepancies, etc.). Questions related to eligibility, or the merits of a specific proposal will not be addressed. The agency anticipates making selections by July 25, 2024, and expects to execute awards by September 14, 2024. These dates are estimates and are subject to change.

This funding opportunity provides financial support for organizations to develop and implement strategies that improve health equity and reduce health disparities among underserved women and girls, particularly those from racial and ethnic minority backgrounds.

This funding opportunity supports research collaborations focused on improving health outcomes and reducing healthcare disparities related to chronic diseases among U.S. Hispanic/Latino populations and in Latin America.

This funding opportunity supports clinical trials focused on innovative cancer research that directly benefits military health and readiness, targeting a range of cancer types and interventions.

This grant provides funding for a wide range of research and technology projects in space and Earth sciences, aimed at organizations and researchers interested in advancing scientific knowledge in these fields.

This funding opportunity provides financial support for training and professional development of individuals from underrepresented backgrounds in health-related research, including students and researchers at various career stages.

This funding opportunity supports innovative research projects aimed at improving health outcomes for individuals affected by the 9/11 attacks and enrolled in the World Trade Center Health Program.

The United States Agency for International Development (USAID) has extended its New Partnerships Initiative (NPI) Global Health Annual Program Statement (APS) to 2030, seeking to engage new and underutilized partners, particularly those locally-based, to expand health sector work and support countries' progress towards self-reliance, with specific funding amounts and application details provided in individual Rounds announced on Grants.gov.

This funding opportunity supports research on the long-term lung health effects of tuberculosis treatment, particularly for individuals co-infected with HIV, aiming to improve understanding and management of post-TB lung disease.

The Regional Alliances and Multistakeholder Partnerships to Stimulate (RAMPS) Cybersecurity Education and Workforce Development (RAMPS) Program seeks to build multistakeholder workforce partnerships of employers, schools and institutions of higher education, and other community organizations. Effective multistakeholder workforce partnerships will organize multiple employers with skill shortages in specific occupations to focus on developing the skilled workforce to meet industry needs within the local or regional economy.

This funding opportunity supports research projects that investigate the health effects and regulatory implications of tobacco products, particularly focusing on diverse populations affected by tobacco use.

This grant provides funding for researchers to develop innovative human cell-based models that mimic the complex structures and functions of the nervous system, particularly focusing on aging and related diseases.

This funding opportunity provides financial support to organizations working in Ukraine to deliver essential HIV prevention, testing, and treatment services, particularly for high-risk populations affected by the ongoing war.

The "Reducing Barriers that Impede Access to Education and Decent Work for LGBTQI+ Youth in Brazil and the Latin American and Caribbean Region" grant is a $4 million funding opportunity from the U.S. Department of Labor to support a project that enhances understanding of, coordination for, and capacity to provide safe environments for LGBTQI+ youth, thereby improving their access to education and decent work in Brazil and the Latin American and Caribbean region.

This funding opportunity supports researchers and organizations developing innovative tissue grafts to restore damaged brain tissue, targeting chronic neurological conditions affecting millions of people.

The FY24 RCRP Concept Award supports highly innovative, untested, potentially groundbreaking novel concepts in rare cancers. The Concept Award is not intended to support an incremental progression of an already established research project; instead, it allows Principal Investigators (PIs) the opportunity to pursue serendipitous observations. Preliminary data are not required. This award mechanism supports high-risk studies that have the potential to reveal entirely new avenues for investigation. Applications must describe how the new idea will enhance the existing knowledge of rare cancers or develop an innovative and novel course of investigation. Research completed through a Concept Award may generate sufficient preliminary data to enable the PI to prepare an application for future research.Reviewers will be blinded to the identity of the Principal Investigator (PI), collaborator(s), and their organization(s). Refer to Section II.D.2.b.i., Full Application Submission Type, for more information.A congressionally mandated Metastatic Cancer Task Force was formed with the purpose of identifying ways to help accelerate clinical and translational research aimed at extending the lives of advanced state and recurrent patients. As a member of the Metastatic Cancer Task Force, CDMRP encourages applicants to review the recommendations (https://health.mil/Reference-Center/Congressional-Testimonies/2018/05/03/Metastatic-Cancer-Research) and submit research ideas to address these recommendations provided they are within the limitations of this funding opportunity and fit within the FY24 RCRP prioritiesInnovative research involving nuclear medicine and related techniques to support early diagnosis, more effective treatment, and improved health outcomes of active-duty Service Members and their Families is encouraged. Such research could improve diagnostic and targeted treatment capabilities through noninvasive techniques and may drive the development of precision imaging and advanced targeted therapies.CDMRP encourages research on health areas and conditions that affect women uniquely, disproportionately, or differently from men, including studies analyzing sex as a biological variable. Such research should relate anticipated project findings to improvements in women's health outcomes and/or advancing knowledge for women's health.All projects should adhere to a core set of standards for rigorous study design and reporting to maximize the reproducibility and translational potential of clinical and preclinical research. The standards are described in SC Landis et al., 2012, A call for transparent reporting to optimize the predictive value of preclinical research, Nature 490:187-191 (https://www.nature.com/nature/journal/v490/n7419/full/nature11556.html). While these standards are written for preclinical studies, the basic principles of randomization, blinding, sample-size estimation, and data handling derive from well-established best practices in clinical studies.Applications from investigators within the military services and applications involving multidisciplinary collaborations among academia, industry, the military services, the U.S. Department of Veterans Affairs, and other federal government agencies are highly encouraged.DOD FY24 Rare Cancers Concept Award 5These relationships can leverage knowledge, infrastructure, and access to unique clinical populations that the collaborators bring to the research effort, ultimately advancing research that is of significance to Service Members, Veterans, and/or their Families. If the proposed research relies on access to unique resources or databases, the application must describe the access at the time of submission and include a plan for maintaining access as needed throughout the proposed research.Clinical trials are not allowed. A clinical trial is defined in the Code of Federal Regulations, Title 45, Part 46.102 (45 CFR 46.102) as a research study in which one or more human subjects are prospectively assigned to one or more interventions (which may include a placebo or another control) to evaluate the effects of the interventions on biomedical or behavioral health-related outcomes.Studies that do not seek to measure safety, effectiveness, and/or efficacy outcome(s) of an intervention are not considered clinical trials.